Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Receptors, IgG | 4 | 2020 | 578 | 1.44 | Why? |
| Immunoglobulin Fc Fragments | 2 | 2019 | 691 | 1.13 | Why? |
| Fucose | 1 | 2019 | 38 | 0.83 | Why? |
| Antigen-Antibody Complex | 2 | 2019 | 408 | 0.79 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2021 | 782 | 0.64 | Why? |
| Immunoglobulin G | 7 | 2020 | 21571 | 0.63 | Why? |
| B-Lymphocytes | 3 | 2020 | 4418 | 0.60 | Why? |
| Severe Dengue | 1 | 2017 | 135 | 0.57 | Why? |
| Antibody-Dependent Enhancement | 1 | 2017 | 413 | 0.49 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.48 | Why? |
| Glycosylation | 3 | 2020 | 1255 | 0.44 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.42 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.39 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.28 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.27 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.21 | Why? |
| Inflammation | 3 | 2021 | 13255 | 0.20 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.18 | Why? |
| Receptors, IgE | 1 | 2017 | 26 | 0.18 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.18 | Why? |
| Health | 1 | 2019 | 130 | 0.17 | Why? |
| Disease | 1 | 2019 | 126 | 0.16 | Why? |
| Protein Structure, Secondary | 1 | 2021 | 1077 | 0.16 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.16 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.16 | Why? |
| Protein Structure, Tertiary | 1 | 2021 | 1565 | 0.16 | Why? |
| Receptors, Fc | 1 | 2017 | 153 | 0.16 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.15 | Why? |
| Antigen Presentation | 1 | 2018 | 524 | 0.14 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.13 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 492 | 0.13 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.13 | Why? |
| RNA Viruses | 1 | 2020 | 824 | 0.12 | Why? |
| Animals | 7 | 2021 | 78931 | 0.12 | Why? |
| Antibody Affinity | 1 | 2017 | 1078 | 0.11 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.10 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.10 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.09 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.08 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.08 | Why? |
| Biosensing Techniques | 1 | 2021 | 2116 | 0.08 | Why? |
| Immunity, Humoral | 2 | 2018 | 4849 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Humans | 17 | 2021 | 930598 | 0.08 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.06 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.06 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.06 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Mice | 1 | 2021 | 21357 | 0.06 | Why? |
| Immunogenetics | 1 | 2020 | 124 | 0.05 | Why? |
| Luminescence | 1 | 2021 | 236 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Injections, Subcutaneous | 1 | 2021 | 647 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Single-Blind Method | 1 | 2021 | 1283 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Transcription, Genetic | 1 | 2020 | 1326 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.03 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| Male | 4 | 2021 | 367725 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Wang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(119)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_